Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Chemico-Biological Interactions|June 25, 2017
ALDHs in normal and malignant hematopoietic cells: Potential new avenues for treatment of AML and other blood cancersMaura Gasparetto, Clayton A Smith
Advances in Experimental Medicine and Biology|November 28, 2014
The effects of alcohol and aldehyde dehydrogenases on disorders of hematopoiesisClay Smith, Maura Gasparetto, Craig Jordan, et al.
Leukemia Research|March 11, 2019
Low ferroportin expression in AML is correlated with good risk cytogenetics, improved outcomes and increased sensitivity to chemotherapyMaura Gasparetto, Shanshan Pei, Mohammad Minhajuddin, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|March 17, 2007
Data quality assessment of ungated flow cytometry data in high throughput experimentsNolwenn Le Meur, Anthony Rossini, Maura Gasparetto, et al.
Annals of the New York Academy of Sciences|March 20, 2014
Aldehyde dehydrogenases in acute myeloid leukemiaClay Smith, Maura Gasparetto, Keith Humphries, et al.
Experimental Hematology|June 20, 2007
Near-maximal expansions of hematopoietic stem cells in culture using NUP98-HOX fusionsHideaki Ohta, Sanja Sekulovic, Silvia Bakovic, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 29, 2007
High-content flow cytometry and temporal data analysis for defining a cellular signature of graft-versus-host diseaseRyan Remy Brinkman, Maura Gasparetto, Shang-Jung Jessica Lee, et al.
International Journal of Cancer|September 19, 2012
Deletion of the RNA-editing enzyme ADAR1 causes regression of established chronic myelogenous leukemia in miceRichard A Steinman, Qiong Yang, Maura Gasparetto, et al.
British Journal of Cancer|September 8, 2017
Aldehyde dehydrogenase 1B1: a novel immunohistological marker for colorectal cancerAkiko Matsumoto, John Arcaroli, Ying Chen, et al.
Pageof 3